Skip to main content
Top
Published in: International Urology and Nephrology 3/2013

01-06-2013 | Urology - Original Paper

Clinical factors associated with shock in bacteremic UTI

Authors: Katsumi Shigemura, Kazushi Tanaka, Kayo Osawa, Sochi Arakawa, Hideaki Miyake, Masato Fujisawa

Published in: International Urology and Nephrology | Issue 3/2013

Login to get access

Abstract

Purpose

Urinary tract infection (UTI) often causes bacteremia, resulting in shock. The purpose of this study is to investigate urological bacteremia and bacteremia shock cases and seek for the clinical factors associated with urological bacteremic shock.

Methods

Seventy consecutive cases with bacteremia caused by UTI from the Department of Urology, Kobe University Hospital were studied. These cases were diagnosed from 2000 to 2010 and had full data available for analysis. We investigated the potential clinical factors associated with bacteremic shock (systolic blood pressure ≤90 mmHg with UTI), including: (1) the number of basal general diseases (such as diabetes, malignancy, immune diseases, heart diseases, liver diseases, and kidney diseases), (2) causative bacteria, (3) antibiotics and therapeutic intervention, (4) gram-negative bacteria, (5) resistance to imipenem (which is often used in this infection), and (6) serum white blood cell counts and C-reactive protein (CRP) at the time of diagnosis of bacteremic UTI.

Results

A total of 81 causative bacteria were isolated: 42 cases were gram-negative and 39 were gram-positive bacteria. In detail, Escherichia coli was the most common, followed by Methicillin-resistant Staphylococcus aureus. The comparison data revealed that urological bacteremic shock cases had significantly increased CRP (p < 0.001). Our univariate analyses showed indwelling urinary tract catheters (p = 0.02) as a significant clinical factor associated with urological bacteremic shock and multivariate analyses showed that the presence of indwelling urinary tract catheters before UTI was a significant clinical factor associated with urological bacteremic shock (p = 0.04).

Conclusions

Indwelling urinary catheters before UTI and high CRP were clinical factors associated with urological bacteremic shock. This result should be considered during decision-making for UTI treatments in high risk cases or urological bacteremia cases.
Literature
1.
go back to reference Bader MS, Hawboldt J, Brooks A (2010) Management of complicated urinary tract infections in the era of antimicrobial resistance. Postgrad Med 122:7–15PubMedCrossRef Bader MS, Hawboldt J, Brooks A (2010) Management of complicated urinary tract infections in the era of antimicrobial resistance. Postgrad Med 122:7–15PubMedCrossRef
3.
go back to reference Ronald A (2003) The etiology of urinary tract infection: traditional and emerging pathogens. Dis Mon 49:71–82PubMedCrossRef Ronald A (2003) The etiology of urinary tract infection: traditional and emerging pathogens. Dis Mon 49:71–82PubMedCrossRef
4.
go back to reference Heyns CF (2012) Urinary tract infection associated with conditions causing urinary tract obstruction and stasis, excluding urolithiasis and neuropathic bladder. World J Urol 30:77–83PubMedCrossRef Heyns CF (2012) Urinary tract infection associated with conditions causing urinary tract obstruction and stasis, excluding urolithiasis and neuropathic bladder. World J Urol 30:77–83PubMedCrossRef
5.
go back to reference Brown PD (2010) Management of urinary tract infections associated with nephrolithiasis. Curr Infect Dis Rep 12:450–454PubMedCrossRef Brown PD (2010) Management of urinary tract infections associated with nephrolithiasis. Curr Infect Dis Rep 12:450–454PubMedCrossRef
6.
go back to reference Geerlings SE (2008) Urinary tract infections in patients with diabetes mellitus: epidemiology, pathogenesis and treatment. Int J Antimicrob Agents 31:S54–S57PubMedCrossRef Geerlings SE (2008) Urinary tract infections in patients with diabetes mellitus: epidemiology, pathogenesis and treatment. Int J Antimicrob Agents 31:S54–S57PubMedCrossRef
7.
go back to reference Geerlings SE, Stolk RP, Camps MJ et al (2000) Asymptomatic bacteriuria may be considered a complication in women with diabetes. Diabetes Mellitus Women Asymptomatic Bacteriuria Utrecht Study Group. Diabetes Care 23:744–749PubMedCrossRef Geerlings SE, Stolk RP, Camps MJ et al (2000) Asymptomatic bacteriuria may be considered a complication in women with diabetes. Diabetes Mellitus Women Asymptomatic Bacteriuria Utrecht Study Group. Diabetes Care 23:744–749PubMedCrossRef
8.
10.
go back to reference Dellinger RP, Levy MM, Rhodes A et al (2013) Surviving sepsis campaign: international guidelines for management of severe sepsis and septicshock, 2012. Intensive Care Med 39:165–228PubMedCrossRef Dellinger RP, Levy MM, Rhodes A et al (2013) Surviving sepsis campaign: international guidelines for management of severe sepsis and septicshock, 2012. Intensive Care Med 39:165–228PubMedCrossRef
11.
go back to reference Clinical and Laboratory Standards Institute (2008) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard 8th edition. Document M07-A8 CLSI, Wayne, PA Clinical and Laboratory Standards Institute (2008) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard 8th edition. Document M07-A8 CLSI, Wayne, PA
12.
go back to reference YokooA Kumamoto Y, Hirose T (1994) Study on intractable factors in urinary tract infections–multiple regression analysis. Kansenshogaku Zasshi 68:905–915 YokooA Kumamoto Y, Hirose T (1994) Study on intractable factors in urinary tract infections–multiple regression analysis. Kansenshogaku Zasshi 68:905–915
13.
go back to reference Nicolle LE (2008) Short-term therapy for urinary tract infection: success and failure. Int J Antimicrob Agents 31:S40–S45PubMedCrossRef Nicolle LE (2008) Short-term therapy for urinary tract infection: success and failure. Int J Antimicrob Agents 31:S40–S45PubMedCrossRef
14.
go back to reference Shigemura K, Arakawa S, Tanaka K et al (2009) Clinical investigation of isolated bacteria from urinary tracts of hospitalized patients and their susceptibilities to antibiotics. J Infect Chemother 15:18–22PubMedCrossRef Shigemura K, Arakawa S, Tanaka K et al (2009) Clinical investigation of isolated bacteria from urinary tracts of hospitalized patients and their susceptibilities to antibiotics. J Infect Chemother 15:18–22PubMedCrossRef
15.
go back to reference Wagenlehner FM, Pilatz A, Weidner W (2011) Urosepsis–from the view of the urologist. Int J Antimicrob Agents 38:S51–S57CrossRef Wagenlehner FM, Pilatz A, Weidner W (2011) Urosepsis–from the view of the urologist. Int J Antimicrob Agents 38:S51–S57CrossRef
16.
go back to reference Hori J, Yamaguchi S, Watanabe M et al (2008) Clinical investigation of extracorporeal endotoxin adsorption therapy in septic urinary tract infections. Nihon Hinyokika Gakkai Zasshi 99:578–583PubMed Hori J, Yamaguchi S, Watanabe M et al (2008) Clinical investigation of extracorporeal endotoxin adsorption therapy in septic urinary tract infections. Nihon Hinyokika Gakkai Zasshi 99:578–583PubMed
17.
go back to reference Guzmàn CA, Pruzzo C, LiPira G et al (1989) Role of adherence in pathogenesis of Enterococcus faecalis urinary tract infection and endocarditis. Infect Immun 57:1834–1838PubMed Guzmàn CA, Pruzzo C, LiPira G et al (1989) Role of adherence in pathogenesis of Enterococcus faecalis urinary tract infection and endocarditis. Infect Immun 57:1834–1838PubMed
18.
go back to reference Tabibian JH, Gornbein J, Heidari A et al (2008) Uropathogens and host characteristics. J Clin Microbiol 46:3980–3986PubMedCrossRef Tabibian JH, Gornbein J, Heidari A et al (2008) Uropathogens and host characteristics. J Clin Microbiol 46:3980–3986PubMedCrossRef
19.
go back to reference Farajnia S, Alikhani MY, Ghotaslou R et al (2009) Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of Iran. Int J Infect Dis 13:140–144PubMedCrossRef Farajnia S, Alikhani MY, Ghotaslou R et al (2009) Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of Iran. Int J Infect Dis 13:140–144PubMedCrossRef
20.
go back to reference Campillo B, Dupeyron C, Richardet JP (2001) Epidemiology of hospital-acquired infections in cirrhotic patients: effect of carriage of methicillin-resistant Staphylococcus aureus and influence of previous antibiotic therapy and norfloxacin prophylaxis. Epidemiol Infect 127:443–450PubMedCrossRef Campillo B, Dupeyron C, Richardet JP (2001) Epidemiology of hospital-acquired infections in cirrhotic patients: effect of carriage of methicillin-resistant Staphylococcus aureus and influence of previous antibiotic therapy and norfloxacin prophylaxis. Epidemiol Infect 127:443–450PubMedCrossRef
21.
go back to reference Wagenlehner FM, Pilatz A, Naber KG et al (2008) Anti-infective treatment of bacterial urinary tract infections. Curr Med Chem 15:1412–1427PubMedCrossRef Wagenlehner FM, Pilatz A, Naber KG et al (2008) Anti-infective treatment of bacterial urinary tract infections. Curr Med Chem 15:1412–1427PubMedCrossRef
22.
go back to reference Amano T, Matsui F, Takashima H et al (2003) Analysis of patients with septic shock due to urosepsis brought on by ureteral calculi. Hinyokika Kiyo 49:1–4PubMed Amano T, Matsui F, Takashima H et al (2003) Analysis of patients with septic shock due to urosepsis brought on by ureteral calculi. Hinyokika Kiyo 49:1–4PubMed
23.
go back to reference Savas L, Guvel S, Onlen Y et al (2006) Nosocomial urinary tract infections: micro-organisms, antibiotic sensitivities and risk factors. West Indian Med J 55:188–193PubMedCrossRef Savas L, Guvel S, Onlen Y et al (2006) Nosocomial urinary tract infections: micro-organisms, antibiotic sensitivities and risk factors. West Indian Med J 55:188–193PubMedCrossRef
24.
go back to reference Ludwig E (2008) Urinary tract infections in diabetes mellitus. Orv Hertil 149:597–600CrossRef Ludwig E (2008) Urinary tract infections in diabetes mellitus. Orv Hertil 149:597–600CrossRef
25.
go back to reference Houdouin V, Bonacorsi S, Bidet P et al (2006) Phylogenetic background and carriage of pathogenicity island-like domains in relation to antibiotic resistance profiles among Escherichia coli urosepsis isolates. J Antimicrob Chemother 58:748–751PubMedCrossRef Houdouin V, Bonacorsi S, Bidet P et al (2006) Phylogenetic background and carriage of pathogenicity island-like domains in relation to antibiotic resistance profiles among Escherichia coli urosepsis isolates. J Antimicrob Chemother 58:748–751PubMedCrossRef
26.
go back to reference Tambyah PA, Oon J (2012) Catheter-associated urinary tract infection. Curr Opin Infect Dis 25:365–370PubMedCrossRef Tambyah PA, Oon J (2012) Catheter-associated urinary tract infection. Curr Opin Infect Dis 25:365–370PubMedCrossRef
Metadata
Title
Clinical factors associated with shock in bacteremic UTI
Authors
Katsumi Shigemura
Kazushi Tanaka
Kayo Osawa
Sochi Arakawa
Hideaki Miyake
Masato Fujisawa
Publication date
01-06-2013
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 3/2013
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-013-0449-4

Other articles of this Issue 3/2013

International Urology and Nephrology 3/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.